EX-99.1 2 v343105_ex99-1.htm EXHIBIT 99.1

 

NEWS
 
Contact:
Margaret M. Loebl
Vice President, Chief Financial Officer & Treasurer
loeblm@quakerchem.com
T. 610.832.4160

 

For Release: Immediate

 

QUAKER CHEMICAL ANNOUNCES FIRST QUARTER 2013 RESULTS

 

·    Solid net sales and operating income despite challenging environment

·    Gross margin improvement

·    Net operating cash flow of $11.3 million enhances strong balance sheet

 

April 29, 2013

 

CONSHOHOCKEN, PA – Quaker Chemical Corporation (NYSE: KWR) today announced net sales and earnings per diluted share of $176.2 million and $1.04 for the first quarter of 2013, respectively, compared to first quarter of 2012 net sales and earnings per diluted share of $177.6 million and $0.95, respectively. Net income for the first quarter of 2013 was $13.6 million compared to net income of $12.4 million for the first quarter of 2012. Non-GAAP earnings per diluted share were $0.96 for the first quarter of 2013 compared to $0.91 for the first quarter of 2012. See Non-GAAP Measures section below.

 

Michael F. Barry, Chairman, Chief Executive Officer and President, commented, “We are pleased to report solid results in the first quarter given the challenging global economic environment. We generated good cash flow and our gross margins are continuing to return to more acceptable levels. Our market share gains and acquisitions have helped us to have relatively stable volumes and revenues despite weak conditions in numerous parts of the world, especially in Europe.

 

Mr. Barry concluded, “Going forward, we believe we will continue to face challenging market conditions around the world with Europe continuing to be the most pronounced. We do, however, remain optimistic about our future and expect 2013 to be another good year for Quaker.”

 

First Quarter of 2013 Summary

 

Net sales for the first quarter of 2013 were $176.2 million, a decrease of less than 1% from $177.6 million in the first quarter of 2012. Foreign exchange rate translation decreased revenues by approximately $2.2 million, or 1%, which was partially offset by a slight increase due to selling and price mix of less than 1%. Product volumes, including acquisitions, were consistent in the first quarter of 2013 compared to the first quarter of 2012.

 

Gross profit increased approximately $2.8 million, or approximately 5%, from the first quarter of 2012. The increase in gross profit on consistent sales was due to an improvement in gross margin to 35.5% compared to 33.7% for the first quarter of 2012 and 34.2% for the fourth quarter of 2012. The increase in gross margin is reflective of the Company’s continuing initiative to restore its margins to more acceptable levels.

 

Quaker Chemical Corporation

One Quaker Park, 901 E. Hector Street, Conshohocken, PA 19428-2380 USA

P: 610.832.4000 F: 610.832.8682

quakerchem.com

 

 
 

 

Selling, general and administrative expenses (“SG&A”) increased approximately $2.1 million compared to the first quarter of 2012, primarily related to increases due to acquisitions, higher incentive compensation and higher selling, inflationary and other labor related costs which were partially offset by a decrease in foreign exchange rate translation.

 

The decrease in interest expense was due to lower average borrowings and lower interest rates experienced in the first quarter of 2013 as compared to the first quarter of 2012.

 

The Company’s effective tax rates for the first quarters of 2013 and 2012 of 24.1% and 21.5%, respectively, reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.10 and $0.12 per diluted share, respectively. Also, contributing to the difference in the effective tax rate is that the tax rate in China was 15% in 2012 compared to 25% in the first quarter of 2013.  While the Company's re-certification of its Chinese subsidiary as a high tech enterprise is pending, the Company will record tax expense at the statutory rate of 25%. The Company has experienced and expects to further experience volatility in its effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, among other factors. The Company estimates that its full year 2013 effective tax rate will be in the high twenty percent range, as compared to the lower rate experienced in the first quarter of 2013.

 

The increase in equity in net income of associated companies was primarily due to higher earnings related to the Company’s equity interest in a captive insurance company in the first quarter of 2013 compared to the first quarter of 2012 of $0.11 and $0.04 per diluted share, respectively. The Company’s first quarter of 2013 equity in net income of associated companies includes a non-cash out of period adjustment of approximately $1.0 million, which primarily related to a reinsurance contract held by the Company’s captive insurance equity affiliate. This increase was partially offset by a charge of approximately $0.03 per diluted share related to the devaluation of the Venezuelan Bolivar Fuerte during the first quarter of 2013.

 

Changes in foreign exchange rates negatively impacted the first quarter of 2013 net income by approximately $0.1 million or $0.01 per diluted share.

 

Balance Sheet and Cash Flow Items

 

Net operating cash flow increased to $11.3 million for the first quarter of 2013 compared to $6.7 million in the first quarter of 2012, which was primarily driven by improved working capital management and the Company’s first dividend distribution from its captive insurance equity affiliate of $2.0 million. The Company’s liquidity continues to be strong, as its cash position exceeded its debt as of March 31, 2013 and its consolidated leverage ratio was less than one times EBITDA.

 

Non-GAAP Measures

 

Included in this public release is a non-GAAP financial measure of non-GAAP earnings per diluted share. The Company believes this non-GAAP financial measure provides meaningful supplemental information as it enhances a reader’s understanding of the financial performance of the Company, is more indicative of future operating performance of the Company, and facilitates a better comparison among fiscal periods, as the non-GAAP measure excludes items that are not considered core to the Company’s operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.

 

-more-
 

 

The following is a reconciliation between the non-GAAP (unaudited) financial measure of non-GAAP earnings per diluted share to its most directly comparable GAAP (unaudited) measure:

 

   Three Months Ended
March 31,
 
   2013   2012 
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders  $1.04   $0.95 
           
Devaluation of the Venezuelan Bolivar per diluted share   0.03     
           
Equity income in a captive insurance company per diluted share   (0.11)   (0.04)
           
Non-GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders  $0.96   $0.91 

 

Forward-Looking Statements

 

This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 

Conference Call

 

As previously announced, Quaker Chemical’s investor conference call to discuss the first quarter of 2013 results is scheduled for April 30, 2013 at 8:30 a.m. (ET). A live webcast of the conference call, together with supplemental information, can be accessed through the Company’s Investor Relations website at http://www.quakerchem.com. You can also access the conference call by dialing 877-269-7756.

 

About Quaker

 

Quaker Chemical is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services. Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.

 

-more-
 

 

Quaker Chemical Corporation

Condensed Consolidated Statement of Income

(Dollars in thousands, except per share data and share amounts)

 

   (Unaudited) 
     
   Three Months Ended March 31, 
   2013   2012 
         
Net sales  $176,193   $177,638 
           
Cost of goods sold   113,585    117,843 
           
Gross profit   62,608    59,795 
%   35.5%   33.7%
           
Selling, general and administrative expenses   45,197    43,093 
           
Operating income   17,411    16,702 
%   9.9%   9.4%
           
Other income, net   346    341 
Interest expense   (744)   (1,174)
Interest income   169    123 
Income before taxes and equity in net income of associated companies   17,182    15,992 
           
Taxes on income before equity in net income of associated companies   4,133    3,445 
Income before equity in net income of associated companies   13,049    12,547 
           
Equity in net income of associated companies   1,142    565 
           
Net income   14,191    13,112 
           
Less: Net income attributable to noncontrolling interest   572    747 
           
Net income attributable to Quaker Chemical Corporation  $13,619   $12,365 
%   7.7%   7.0%
           
Per share data:          
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic  $1.04   $0.96 
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted  $1.04   $0.95 

 

-more-
 

 

Quaker Chemical Corporation

Condensed Consolidated Balance Sheet

(Dollars in thousands, except par value and share amounts)

 

   (Unaudited) 
         
   March 31,   December 31, 
   2013   2012 
ASSETS          
           
Current assets          
Cash and cash equivalents  $35,256   $32,547 
Accounts receivable, net   157,163    154,197 
Inventories   73,965    72,471 
Prepaid expenses and other current assets   17,763    18,595 
Total current assets   284,147    277,810 
           
Property, plant and equipment, net   84,928    85,112 
Goodwill   59,248    59,169 
Other intangible assets, net   32,972    32,809 
Investments in associated companies   15,605    16,603 
Deferred income taxes   28,935    30,673 
Other assets   34,752    34,458 
Total assets  $540,587   $536,634 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Short-term borrowings and current portion of long-term debt  $1,905   $1,468 
Accounts and other payables   74,807    70,794 
Accrued compensation   11,016    16,842 
Other current liabilities   25,280    18,688 
Total current liabilities   113,008    107,792 
Long-term debt   27,675    30,000 
Deferred income taxes   6,256    6,383 
Other non-current liabilities   91,675    102,783 
Total liabilities   238,614    246,958 
           
Equity          
Common stock, $1 par value; authorized 30,000,000 shares; issued 13,139,691   13,140    13,095 
Capital in excess of par value   95,775    94,470 
Retained earnings   225,790    215,390 
Accumulated other comprehensive loss   (41,747)   (41,855)
Total Quaker shareholders' equity   292,958    281,100 
Noncontrolling interest   9,015    8,576 
Total equity   301,973    289,676 
Total liabilities and equity  $540,587   $536,634 

 

-more-
 

 

Quaker Chemical Corporation

Condensed Consolidated Statement of Cash Flows

For the three months ended March 31,

(Dollars in thousands)

 

   (Unaudited) 
   2013   2012 
Cash flows from operating activities          
Net income  $14,191   $13,112 
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation   3,056    3,057 
Amortization   879    746 
Equity in undistributed earnings of associated companies, net of dividends   921    (381)
Deferred compensation and other, net   (861)   (103)
Stock-based compensation   1,040    1,186 
Gain on disposal of property, plant and equipment   (2)   (14)
Insurance settlement realized   -    (483)
Pension and other postretirement benefits   (2,521)   (2,357)
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:          
Accounts receivable   (3,977)   (9,764)
Inventories   (1,837)   352 
Prepaid expenses and other current assets   (457)   (557)
Accounts payable and accrued liabilities   874    1,938 
Net cash provided by operating activities   11,306    6,732 
           
Cash flows from investing activities          
Investments in property, plant and equipment   (2,723)   (3,178)
Payments related to acquisitions, net of cash acquired   (647)   - 
Proceeds from disposition of assets   13    64 
Insurance settlement received and interest earned   14    18 
Change in restricted cash, net   (14)   465 
Net cash used in investing activities   (3,357)   (2,631)
           
Cash flows from financing activities          
Net increase in short-term borrowings   594    - 
Proceeds from long-term debt   -    1,350 
Repayment of long-term debt   (2,438)   (189)
Dividends paid   (3,208)   (3,105)
Stock options exercised, other   (59)   (1,288)
Excess tax benefit related to stock option exercises   369    546 
Net cash used in financing activities   (4,742)   (2,686)
           
Effect of exchange rate changes on cash   (498)   640 
Net increase in cash and cash equivalents   2,709    2,055 
Cash and cash equivalents at the beginning of the period   32,547    16,909 
Cash and cash equivalents at the end of the period  $35,256   $18,964